Related Experiment Videos
Therapy options in Alzheimer's disease
1Göteborg University, Department of Clinical Neuroscience, Mölndal, Sweden.
The British Journal of Clinical Practice
|November 1, 1994
Summary
Preventing Alzheimer's disease (AD/SDAT) is challenging due to unknown causes. Secondary prevention strategies focus on managing stress and nutritional deficiencies, alongside experimental treatments for cognitive decline and emotional disturbances.
Area of Science:
- Neurology
- Gerontology
- Pharmacology
Background:
- The exact causes of Alzheimer's disease and senile dementia of the Alzheimer type (AD/SDAT) remain unknown, hindering primary prevention efforts.
- Common factors observed in AD/SDAT patients include overactivity of the hypothalamic-pituitary-adrenal axis, suggesting stress-related maladaptation, and vitamin B12 deficiency.
Purpose of the Study:
- To review current understanding and potential strategies for the secondary prevention and treatment of Alzheimer's disease and senile dementia of the Alzheimer type (AD/SDAT).
- To highlight emerging therapeutic avenues and existing treatments for cognitive and emotional symptoms associated with AD/SDAT.
Main Methods:
- Review of existing literature on the etiology, risk factors, and treatment modalities for AD/SDAT.
- Analysis of experimental and clinical trial data for various therapeutic interventions.
Main Results:
- Secondary prevention strategies should target stress management and dietary factors, particularly vitamin B12 levels.
- Experimental treatments like nerve growth factors, ganglioside GM1, and amyloid formation inhibitors show promise but require further research.
- Pharmacological interventions such as tacrine (acetylcholinesterase inhibitor) offer temporary cognitive enhancement with side effects, while selective serotonin reuptake inhibitors can manage emotional disturbances.
Conclusions:
- Current AD/SDAT management focuses on secondary prevention through lifestyle and nutritional interventions, alongside exploring novel therapeutic agents.
- While some treatments demonstrate efficacy for symptoms, the lack of a definitive cure necessitates continued research into disease mechanisms and treatment development.